UPDATE TO RFA-AE-10-001: OS Recovery Act Limited Competition: Accelerating Adoption of Comparative Effectiveness Research Results by Providers and Patients (R18) - Announcing Additional Funds Availability and Clarifying Eligible Institutions/Organizations

Notice Number: NOT-AE-10-001

Key Dates
Release Date: February 10, 2010

Issued by
Office of the Assistant Secretary for Planning and Evaluation (ASPE) (http://www.aspe.hhs.gov)

In January, 2010, ASPE announced the availability of funds under the American Recovery and Reinvestment Act of 2009 (ARRA) for strategies for accelerating the adoption of comparative effectiveness research (CER) results by providers and patients (RFA-AE-10-001). Since then, additional funds have been made available for this RFA in order to allow for the funding of 1 to 3 additional meritorious proposals, thus broadening the impact of this critical component of the CER enterprise. These additional funds will lead to a greater understanding of “best practices” for the adoption of CER by both providers and patients.  In addition, ASPE is clarifying additional eligible institution/organization characteristics.

This Notice serves to notify potential applicants of the following changes or clarifications related to the Funds Available and Eligible Institutions/Organizations:

Of note, ASPE is clarifying that the eligible institutions or organizations with the following characteristics may also include the following:

No other changes are being made to the funding opportunity announcement at this time.

This Notice is subject to restrictions on oral conversations during the period of time commencing with the submission of a formal application by an individual or entity and ending with the award of the competitive funds. Federal officials may not participate in oral communications initiated by any person or entity concerning a pending application for a Recovery Act competitive grant or other competitive form of Federal financial assistance, whether or not the initiating party is a federally registered lobbyist. This restriction applies unless:

(i) the communication is purely logistical;

(ii) the communication is made at a widely attended gathering;

(iii) the communication is to or from a Federal agency official and another Federal Government employee;

(iv) the communication is to or from a Federal agency official and an elected chief executive of a state, local or tribal government, or to or from a Federal agency official and the Presiding Officer or Majority Leader in each chamber of a state legislature; or

(v) the communication is initiated by the Federal agency official.

For additional information see http://www.whitehouse.gov/omb/assets/memoranda_fy2009/m09-24.pdf

We encourage your inquiries concerning this funding opportunity and welcome the opportunity to answer questions from potential applicants. Inquiries may fall into three areas: scientific/research (program), peer review, and financial or grants management issues:

Questions concerning this Notice should be referred to the Scientific/Research Contact:

Patrick Conway, MD, MSc
Office of the Assistant Secretary for Planning and Evaluation
Office of the Secretary
Department of Health and Human Services
Room 415 F 
200 Independence Ave. SW
Washington, DC 20201
Phone: (202) 690-7858
Fax: (202) 690-7383
Email: patrick.conway@hhs.gov

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices

Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy

Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.